10-101775156-G-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 3P and 9B. PM1PP2BP4_StrongBP6BS1

The NM_033163.5(FGF8):​c.130C>T​(p.Arg44Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000976 in 1,547,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R44P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

FGF8
NM_033163.5 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.0990

Publications

0 publications found
Variant links:
Genes affected
FGF8 (HGNC:3686): (fibroblast growth factor 8) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein is known to be a factor that supports androgen and anchorage independent growth of mammary tumor cells. Overexpression of this gene has been shown to increase tumor growth and angiogensis. The adult expression of this gene is restricted to testes and ovaries. Temporal and spatial pattern of this gene expression suggests its function as an embryonic epithelial factor. Studies of the mouse and chick homologs revealed roles in midbrain and limb development, organogenesis, embryo gastrulation and left-right axis determination. The alternative splicing of this gene results in four transcript variants. [provided by RefSeq, Jul 2008]
FGF8 Gene-Disease associations (from GenCC):
  • hypogonadotropic hypogonadism 6 with or without anosmia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypogonadotropic hypogonadism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Kallmann syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PM1
In a chain Fibroblast growth factor 8 (size 210) in uniprot entity FGF8_HUMAN there are 12 pathogenic changes around while only 5 benign (71%) in NM_033163.5
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 12 curated pathogenic missense variants (we use a threshold of 10). The gene has 3 curated benign missense variants. Gene score misZ: 1.5674 (below the threshold of 3.09). Trascript score misZ: 1.0113 (below the threshold of 3.09). GenCC associations: The gene is linked to hypogonadotropic hypogonadism, holoprosencephaly, hypogonadotropic hypogonadism 6 with or without anosmia, Kallmann syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.02870676).
BP6
Variant 10-101775156-G-A is Benign according to our data. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461. Variant chr10-101775156-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 545461.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000591 (9/152168) while in subpopulation SAS AF = 0.000827 (4/4834). AF 95% confidence interval is 0.000282. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGF8NM_033163.5 linkc.130C>T p.Arg44Trp missense_variant Exon 3 of 6 ENST00000320185.7 NP_149353.1 P55075-4A1A515

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGF8ENST00000320185.7 linkc.130C>T p.Arg44Trp missense_variant Exon 3 of 6 1 NM_033163.5 ENSP00000321797.2 P55075-4

Frequencies

GnomAD3 genomes
AF:
0.0000591
AC:
9
AN:
152168
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000140
AC:
21
AN:
149474
AF XY:
0.000149
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000356
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000102
AC:
142
AN:
1395728
Hom.:
0
Cov.:
32
AF XY:
0.000129
AC XY:
89
AN XY:
688446
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31534
American (AMR)
AF:
0.00
AC:
0
AN:
35766
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25184
East Asian (EAS)
AF:
0.0000559
AC:
2
AN:
35764
South Asian (SAS)
AF:
0.000846
AC:
67
AN:
79178
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47774
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4114
European-Non Finnish (NFE)
AF:
0.0000649
AC:
70
AN:
1078606
Other (OTH)
AF:
0.0000519
AC:
3
AN:
57808
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000591
AC:
9
AN:
152168
Hom.:
0
Cov.:
31
AF XY:
0.0000807
AC XY:
6
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41456
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000827
AC:
4
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68006
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000854
AC:
8
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Peters plus syndrome Uncertain:1
May 24, 2018
Genomic Medicine Lab, University of California San Francisco
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly sequence Benign:1
Apr 20, 2018
Muenke lab, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Compatible clinical findings, but predicted to be benign on the basis of experimental data and ACMG criteria:BS3/BS1;BP4. Six unrelated detections in ExAC exceeds the birth incidence of Holopresencephaly (1:10,1000 to 1:20,000). -

not provided Benign:1
Jan 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.55
D;.
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.49
FATHMM_MKL
Benign
0.63
D
LIST_S2
Benign
0.70
T;T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.029
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.0
L;L
PhyloP100
0.099
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.21
N;N
REVEL
Benign
0.19
Sift
Benign
0.067
T;T
Sift4G
Uncertain
0.056
T;T
Polyphen
0.0010
B;B
Vest4
0.19
MutPred
0.47
Loss of disorder (P = 3e-04);Loss of disorder (P = 3e-04);
MVP
0.48
MPC
0.86
ClinPred
0.073
T
GERP RS
0.85
Varity_R
0.057
gMVP
0.63
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781205876; hg19: chr10-103534913; API